Printed on 3/17/2026
For informational purposes only. This is not medical advice.
The Generalized Anxiety Disorder 2-item scale (GAD-2) is an ultra-brief anxiety screening tool consisting of the first two items of the GAD-7. It asks about the frequency of feeling nervous or anxious and inability to control worrying over the past two weeks. Each item is scored 0-3, yielding a total score of 0-6. A score of 3 or higher is the standard cutoff for a positive screen, with a sensitivity of 86% and specificity of 83% for generalized anxiety disorder. Like the [PHQ-2](/tools/phq2), it is designed as a rapid first-step screener to identify patients who need further assessment. Full assessment: [GAD-7](/tools/gad7). Comorbid depression: [PHQ-9](/tools/phq9). Trauma screening: [PCL-5](/tools/pcl5).
Formula: Total score = sum of 2 items (each 0-3). Range 0-6. Positive screen ≥ 3.
Rate how often you've felt nervous/anxious and unable to control worrying over the past 2 weeks using a 0-3 scale: not at all, several days, more than half the days, or nearly every day.
Your two answers are summed for a total score from 0 to 6. This ultra-brief screen takes less than 30 seconds to complete.
A score of 3 or higher is a positive screen (86% sensitivity, 83% specificity) and should prompt the full GAD-7 or a clinical interview for comprehensive anxiety assessment.
Family physicians & internists
Include the GAD-2 on intake forms alongside the PHQ-2. Together, these 4 questions screen for both anxiety and depression—the two most common mental health conditions—in under 2 minutes.
ED nurses & physicians
Quickly identify anxiety in patients presenting with somatic complaints like chest pain, shortness of breath, or palpitations that may have an anxiety component.
Employee assistance programs
Screen employees for anxiety during wellness checkups or when work stress is suspected. Early identification enables intervention before anxiety affects job performance.
University mental health services
Anxiety is the most common mental health concern among college students. The GAD-2 allows rapid triage of students seeking counseling services.
Specialty clinics
Anxiety commonly co-occurs with chronic conditions like diabetes, heart disease, and COPD. Quick screening identifies patients who may benefit from integrated mental health support.
Individuals wondering about anxiety
If you're wondering whether your worry is normal or excessive, the GAD-2 provides a quick, evidence-based starting point before seeking professional evaluation.
The GAD-2 asks about the last 2 weeks specifically. Answer based on this recent period, not chronic baseline anxiety or past episodes.
Excessive worry and inability to control that worry are the defining features of generalized anxiety disorder. If both are absent, GAD is unlikely.
Anxiety and depression frequently co-occur (up to 60% comorbidity). The GAD-2 + PHQ-2 combination (4 questions) screens both conditions efficiently.
A score of 2 with high clinical suspicion (panic attacks, avoidance behaviors, functional impairment) may still warrant the full GAD-7 or clinical evaluation.
While developed for generalized anxiety disorder, the GAD-2 has moderate sensitivity for panic disorder, social anxiety, and other anxiety disorders. It's a general anxiety screen.
At 86% sensitivity, some anxious patients screen negative, especially those with anxiety disorders where worry isn't the primary feature (specific phobias, panic disorder, PTSD).
Hyperthyroidism, caffeine excess, stimulant medications, and medication withdrawal can cause anxiety symptoms. Consider medical evaluation if symptoms are new or atypical.
Use the full GAD-7 to track treatment response. The GAD-2 lacks the granularity to detect meaningful changes in anxiety severity over time.
Your GAD-2 score ranges from 0 to 6 and reflects the frequency of two core anxiety symptoms: feeling nervous or anxious and inability to stop or control worrying. A score of 0-2 is considered a negative screen, suggesting that clinically significant anxiety is unlikely at this time. A score of 3 or higher is a positive screen with a sensitivity of 86% and specificity of 83% for generalized anxiety disorder, indicating that further evaluation with the full GAD-7 or a clinical interview is recommended.
A positive screen does not confirm an anxiety disorder diagnosis. Many people experience transient anxiety related to life stressors, medical procedures, or situational factors that may elevate their score without meeting criteria for a clinical disorder. The GAD-2 identifies patients who need further assessment to distinguish normal worry from pathological anxiety.
The GAD-2 is designed for rapid anxiety screening in high-volume clinical settings. It is commonly used alongside the PHQ-2 as part of a brief four-question mental health screen covering both depression and anxiety. This combination is practical for primary care intake forms, annual wellness visits, and pre-operative assessments.
It is also useful in settings where the full GAD-7 would be too time-consuming, such as emergency departments, walk-in clinics, or large-scale population health screening programs. When the GAD-2 is positive, clinicians should follow up with the full GAD-7 for severity assessment or proceed directly to a clinical interview.
The GAD-2 captures only two of the seven GAD-7 items and cannot characterize anxiety severity or monitor treatment response. It is strictly a gate-keeping screener and should always be followed by more comprehensive assessment when positive.
While developed for generalized anxiety disorder, the GAD-2 has moderate sensitivity for other anxiety disorders (panic disorder, social anxiety, PTSD) but may miss cases where the primary symptoms are somatic (palpitations, tremor, gastrointestinal distress) or disorder-specific (avoidance in social anxiety, flashbacks in PTSD). Disorder-specific screening tools are more appropriate when a particular anxiety disorder is suspected.
The GAD-2 does not distinguish between anxiety disorders and anxiety symptoms caused by medical conditions such as hyperthyroidism, stimulant use, caffeine excess, or medication side effects. A clinical interview is needed to establish the correct diagnosis and rule out medical causes of anxiety symptoms.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
Free GAD-7 anxiety screening questionnaire. Take the Generalized Anxiety Disorder 7-item scale to assess anxiety severity with instant scoring and interpretation. Also screen for depression with [PHQ-9](/tools/phq9).
Mental HealthQuick two-question depression screen using the PHQ-2. A score of 3 or higher suggests further evaluation with the full [PHQ-9](/tools/phq9).
Mental HealthFree PHQ-9 depression screening questionnaire. Take the Patient Health Questionnaire-9 to assess depression severity with instant scoring and interpretation. Also screen for anxiety with [GAD-7](/tools/gad7).